Janus Henderson Group
ORIC icon

Janus Henderson Group’s Oric Pharmaceuticals ORIC Stock Holding History

Janus Henderson Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Hold
14,400
– – ﹤0.01% 2343
2025
Q4 		$118K Hold
14,400
– – ﹤0.01% 2389
2025
Q3 		$173K Buy
+14,400
New +$152K ﹤0.01% 2361
2025
Q2 		– Sell
-14,600
Closed -$89.7K – 2483
2025
Q1 		$89.7K Hold
14,600
– – ﹤0.01% 2465
2024
Q4 		$118K Buy
+14,600
New +$134K ﹤0.01% 2501
2024
Q1 		– Sell
-659,054
Closed -$6.07M – 2565
2023
Q4 		$6.07M Buy
+659,054
New +$4.77M ﹤0.01% 768

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Janus Henderson Group's ORIC Position: Q1 2026 in Review

Janus Henderson Group held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 14,400 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

Janus Henderson Group first reported a position in ORIC in Q4 2023 and has held it in 6 quarters since. The position peaked at $6.07M in Q4 2023. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Janus Henderson Group held 14,400 shares of Oric Pharmaceuticals worth $182K as of Q1 2026.
  • Janus Henderson Group left its Oric Pharmaceuticals share count unchanged in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2343 holding.
  • Janus Henderson Group first reported a position in Oric Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • Janus Henderson Group's Oric Pharmaceuticals position peaked at $6.07M in Q4 2023.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.